World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 27 May 2013
Main ID:  NTR898
Date of registration: 09/02/2007
Primary sponsor: Erasmus Medical Center, Department of Orthopaedics
Public title: Is a simultaneaus intervention of triamcinolon injections with standardized exercises more effective compared to the usual care according to the NHG standard in patients with shoulder complaints. A prospective, singel blind, randomized clinical trial.
Scientific title: Is a simultaneaus intervention of triamcinolon injections with standardized exercises more effective compared to the usual care according to the NHG standard in patients with shoulder complaints. A prospective, singel blind, randomized clinical trial. - Investigation of the efficacy of shoulder injections
Date of first enrolment: 1/6/2007
Target sample size: 205
Recruitment status: pending
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=898
Study type:  intervention
Study design:  Randomised: Yes; Masking: Single; Control: Active; Group: Parallel; Type: -  
Countries of recruitment
The Netherlands
Contacts
Name: B.J   Berkhout
Address:  Vrieseweg 157 3311 NV Dordrecht The Netherlands
Telephone: +31 78-6144000
Email: email: berkh994@planet.nl
Affiliation: 
Name: B.J   Berkhout
Address:  Vrieseweg 157 3311 NV Dordrecht The Netherlands
Telephone: +31 78-6144000
Email: email: berkh994@planet.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients with shoulder complaints consulting their GP;
2. Presence of painfull-arc and restricted range of motion.

Exclusion criteria: 1. Not signed informed consent form;
2. Age under 18 or above 70 year;
3. Treatment (exercises or corticosteroid injections) of shoulder complaints during the last 6 months;
4. Insufficient command of the Dutch language, spoken and/or written.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Complaints of shoulder, Triamcinolone injections, NHG standard, Exercises, Efficacy

Intervention(s)
Group A: a simultaneus intervention in which the patients will be injected with a combination of lidocaine and 1 ml Kenacort A40 and at the same time exercises; and group B in which the patient will be injected with a combination of lidocaine and 1 ml Kenacort A40 and after six weeks according to the NHG-standard with exercises.
Primary Outcome(s)
The primary outcome is the change in pain in rest, during activities or during the night of the last 24 hours, between baseline and 78 weeks.
Secondary Outcome(s)
Change compared to the baseline assessments of:
1. DASH questionnaire;
2. SF36 questionnaire;
3. Analgetica use;
4. Participant rated improvement;
5. Range of Motion maesurements;
6. Painful-Arc;
7. Complications of injections.
Secondary ID(s)
ISRCTN75642432
N/A
Source(s) of Monetary Support
Erasmus Medical Center, Department of Orthopaedics
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history